It looks like SAGE is being pumped and kept above $45 for a secondary. My plan is to short on a pop tomorrow or at the close today. With so much pumping it could have a little pop between today and tomorrow.
PII, only 21 patients, placebo effect, need funding, easy short. We've seen this game played so many times.
Wow, so all I have to do is buy every bio with PIII data and I'll be a billionaire in a few months. Awsome!
Note that the bid/ask spread in no longer crazy like the past few days. The algo that had control is now turned off.
Actually it's quite the opposite of what you believe. Many retail bio "investors" become emotionally attached to their stocks. Many are also hoping to get rich overnight, which does happen. The day traders are looking to take advantage of emotionally charged price swings in either direction.
Each has their own important role in the market. Traders add liquidity to the market and keep prices in check. Investors form the bedrock of the market.
Was able to get in just above you today. I never hold overnight. Yesterday was awesome in that it traded in a $1 range six times yesterday. Now that the offering is closed the algo will soon be turned off and the stock will fall.
So 1/3 of the company's value was in one phase II drug trial? Is this right?
If XBI is up 0.20%, but LABU is down 0.20%
-Why is there such a huge difference if one tracks the other?
-Does the market maker have a responsibility to correct the variance?
I see this mostly when the markets are somewhat flat.
The fact that the secondary still hasn't closed tells us that institutions aren't exactly beating down the doors to buy at $81.